Journal article

Inhibition of the pore-forming protein perforin by a series of aryl-substituted isobenzofuran-1(3H)-ones

JA Spicer, KM Huttunen, CK Miller, WA Denny, A Ciccone, KA Browne, JA Trapani

Bioorganic and Medicinal Chemistry | Published : 2012

Abstract

An aryl-substituted isobenzofuran-1(3H)-one lead compound was identified from a high throughput screen designed to find inhibitors of the lymphocyte pore-forming protein perforin. A series of analogs were then designed and prepared, exploring structure-activity relationships through variation of 2-thioxoimidazolidin-4-one and furan subunits on an isobenzofuranone core. The ability of the resulting compounds to inhibit the lytic activity of both isolated perforin protein and perforin delivered in situ by intact KHYG-1 natural killer effector cells was determined. Several compounds showed excellent activity at concentrations that were non-toxic to the killer cells. This series represents a sig..

View full abstract

University of Melbourne Researchers

Grants

Awarded by Wellcome Trust


Funding Acknowledgements

This work was supported by the Wellcome Trust (Grant 092717) and the Auckland Division of the Cancer Society of New Zealand. K. M. H. thanks the Academy of Finland (Grant 135439), the Finnish Cultural Foundation, and Jenny and Antti Wihuri Foundation for financial support. We also thank Sisira Kumara and Karin Tan for HPLC studies, and Maruta Boyd and Shannon Black for NMR studies.